FZMD vs BSX: Which Stock is Better?
Side-by-side comparison of Fuse Medical, Inc. and Boston Scientific Corp in 2026
FZMD
Fuse Medical, Inc.
$0.04
BSX
Boston Scientific Corp
$64.23
Key Metrics Comparison
| Metric | FZMD | BSX | Winner |
|---|---|---|---|
| Market Cap | $2.96M | $95.46B | BSX |
| P/E Ratio | 1.33 | 33.11 | FZMD |
| EPS (TTM) | $0.03 | $1.94 | BSX |
| Revenue Growth | 0.1% | 0.2% | BSX |
| Gross Margin | 67.2% | 68.8% | BSX |
Analyze FZMD
Full quant analysis
Analyze BSX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is FZMD or BSX a better investment?
Comparing FZMD and BSX: Fuse Medical, Inc. has a market cap of $2.96M while Boston Scientific Corp has $95.46B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between FZMD and BSX?
FZMD (Fuse Medical, Inc.) and BSX (Boston Scientific Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: FZMD or BSX?
Based on P/E ratios, FZMD trades at a lower multiple (1.3x vs 33.1x).
Which is growing faster: FZMD or BSX?
BSX has higher revenue growth at 0.2% vs 0.1% for FZMD.
Which company is more profitable: FZMD or BSX?
Boston Scientific Corp (BSX) has higher gross margins at 68.8% compared to 67.2% for FZMD.
Which is the larger company: FZMD or BSX?
Boston Scientific Corp (BSX) is larger with a market cap of $95.46B compared to $2.96M for FZMD.
Should I buy FZMD or BSX in 2026?
Both FZMD and BSX have investment merit. FZMD trades at $0.04 while BSX trades at $64.23. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between FZMD and BSX stock?
Key differences: Market Cap ($2.96M vs $95.46B), P/E Ratio (1.3x vs 33.1x), Revenue Growth (0.1% vs 0.2%), Gross Margin (67.2% vs 68.8%).